A multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community has received a $21 million grant from the ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

A recent study published in Synthese challenges the default collection and reliance on ethno-racial data in biomedical ...

NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete response rates ...

IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...

Zoonotic diseases, also known as zoonoses, bridge the gap between animal and human health, marking a prominent area of concern for global public health.

In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Gilbert, Arizona-- (Newsfile Corp. - January 2, 2025) - A Race Against Blindness, an Arizona-based nonprofit organization, has awarded a $1 million grant to fund research and clinical trials focused ...

A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and ...